HOME >> MEDICINE >> NEWS
Coupling of brain proteins may prompt new treatments for schizophrenia, addiction

Researchers at the University of Toronto, the Centre for Addiction and Mental Health (CAMH) and the Hospital for Sick Children (HSC) have discovered a cellular communication method in the brain that could lead to improved treatments for schizophrenia and addiction.

Many of the symptoms associated with schizophrenia and addiction are caused by either too much or too little dopamine and GABA, chemicals in the brain that help regulate learning, memory, emotion and cognition. In a study published in the Jan. 20 edition of the journal Nature, researchers demonstrate how proteins can modify each other's function - including the ability of neurons to accept or reject dopamine and other neurochemicals - by binding to each other.

"What we found is a previously unknown method of signal transduction between two structurally different neurotransmitter receptor systems, that is, the direct physical coupling of these proteins," says senior author Dr. Hyman Niznik, associate professor of psychiatry and pharmacology at U of T and section head, laboratory and molecular neurobiology at CAMH. "This may provide us with a new therapeutic window on how to restore normal cellular function in diseases like schizophrenia with the right medication that can either block this interaction or make it happen." Brain cells communicate with each other via neurotransmitters - natural chemicals that interact with proteins, or receptors, on adjacent neurons. There are many different types of receptors in the brain, some of which respond only to dopamine and some only to the neurotransmitter GABA [g-aminobutyric acid]. Of the many dopamine receptors, two - D1 and D5 - are very similar and respond to the same drugs. Many of the negative symptoms of schizophrenia and addiction are regulated by D1-like receptors.

Niznik and his team of researchers demonstrated that dopamine D5 receptors can directly modify the function of GABA receptors by directly binding to them and forming
'"/>

Contact: Megan Easton
megan.easton@utoronto.ca
416-978-5948
University of Toronto
18-Jan-2000


Page: 1 2

Related medicine news :

1. Some brain cells change channels to fine-tune the message
2. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
3. Can you read my mind? W.M. Keck Foundation funds innovative brain research at Carnegie Mellon
4. Scientist works on innovative treatments for brain tumors
5. Mechanism of RNA recoding: New twists in brain protein production
6. Does the college experience damage your brain?
7. Dartmouth researchers find where musical memories are stored in the brain
8. Common anesthetics appear safe for developing fetal brain
9. Breakthrough in medical research: New chemotherapy gives hope to brain tumour patients
10. New scale predicts recovery of consciousness from coma after brain injury
11. Study: Two brain systems regulate how we call for help

Post Your Comments:
(Date:11/21/2014)... VogueQueen has released 18 new beach wedding ... coming holiday season. People who register at VogueQueen.com now ... The beach wedding dresses from VogueQueen.com have been very ... the premium quality fabrics and dedicated craftsmanship. These products ... environment, they would bring more fun to a lady’s ...
(Date:11/21/2014)... 2014 Midway through the research period ... (AIS) annual Directory of Health Plans, preliminary data shows ... of Health Plans is a comprehensive resource with enrollment ... the U.S. The 2015 edition will be ... Directory and Databases Division, the company’s exclusive in-house research ...
(Date:11/21/2014)... 2014 TruDenta, the creator of a ... and other jaw-related symptoms, has reported a nationwide rise ... head pain, neck pain, TMJ (temporomandibular joint) disorder, jaw ... have seen a 52% increase in the number of ... 300 doctors and their teams in 47 states are ...
(Date:11/21/2014)... 2014 Recently, DressVe.com , a renowned ... announced a new collection of fashion accessories. Furthermore, the company ... up to 95% off, on all its fashion items. Also, ... to the CEO of the company, their wedding dresses and ... now available at greatly discounted rates. , The CEO ...
(Date:11/21/2014)... November 21, 2014 Recently, TideStore.com, a ... accessories, has announced its special offer TideStore Thanksgiving ... items at TideStore.com are now provided with big discounts. ... 25. People can enjoy an extra 10% discount with ... their email addresses and have opportunities to win free ...
Breaking Medicine News(10 mins):Health News:Beach Wedding Dresses on Sale for the Coming Holiday Season at VogueQueen.com 2Health News:Data from Atlantic Information Services’s Forthcoming Directory Shows Volatility in U.S. Health Care Market 2Health News:National Rise In Patients Seeking Headache Relief 2Health News:DressVe.com Announces Its 2014 Special Friday Sales 2Health News:Thanksgiving Sales from TideStore.com 2
(Date:11/21/2014)... November 2014 Clementia ... gegeben, dass die Europäische Arzneimittel-Agentur (European ... als Orphan-Medizinprodukt an Palovarotene vergeben hat, ... Behandlung von Fibrodysplasia ossificans progressiva (FOP). ... genetische Krankheit, die von schmerzhaften, wiederkehrenden ...
(Date:11/21/2014)... DUBLIN, Ohio and MELVILLE, N.Y. ... (NYSE: CAH ), one of the world,s ... (NASDAQ: HSIC ), the world,s largest provider ... animal health and medical practitioners, today announced that the ... provide one of the most comprehensive service and product ...
(Date:11/21/2014)... YORK , Nov. 20, 2014  Market research firm ... the "Year of The Buy, in the medical device ... for medical devices will produce just 3% growth this ... actions, including acquisitions of product lines and entrance by ... annual survey of medical devices, The Global Market ...
Breaking Medicine Technology:Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 2Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 4Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 5Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2
Cached News: